Results 201 to 210 of about 1,048,092 (262)

Human Absorption, Metabolism, and Excretion (hAME) Mass Balance Studies in Patients With Cancer. [PDF]

Clin Transl Sci
Heras BL, Oelke C, Atwell P, Herrero H, Nunes P, Saini KS, Boixader LV, Laing C, Bush J, Calvo E.   +9 more
europepmc   +1 more source

693 drugs in essential drugs list.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1999
openaire   +1 more source

Challenges facing long-acting PrEP implementation in large populations. [PDF]

Emerg Microbes Infect
Sun C, Liao Y.
europepmc   +1 more source

Antibody-drug conjugates for infectious and neglected tropical diseases: chemical design principles, target biology, and translational challenges. [PDF]

Front Chem
Reddy D, Jeena V, Papo TR, Ohaekenyem EC.   +3 more
europepmc   +1 more source

Applications of Selected Nanoencapsulated Indigenous Essential Oils in Medicine, Food, and Agriculture: A Review. [PDF]

Foods
Wutu OS, Mpambani B, Naidoo CM.
europepmc   +1 more source

Editorial: Optimizing medication management in older adults: addressing polypharmacy, deprescribing and represcribing challenges. [PDF]

Front Med (Lausanne)
Garfinkel D, Wehling M, Scott I.
europepmc   +1 more source

Attitudes and practices of stakeholders regarding HIV service delivery for pregnant and lactating women amid the COVID-19 Pandemic in Uganda

Twimukye A, Waitt C, Gonza P, Olungah CO.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Emerging drugs for essential thrombocythemia

Expert Opinion on Emerging Drugs, 2019
Introduction: Despite our recent progress in the understanding of essential thrombocythemia (ET) pathogenesis, the therapeutic management of this disease has remained largely unchanged in the past decades. Treatment has mostly focused on decreasing the risk of complications, especially prevention of thrombotic or hemorrhagic events. Areas covered: Over
Lucia Masarova, Srdan Verstovsek
openaire   +2 more sources

The economics of essential drug programmes

Social Science & Medicine, 1987
Public health measures are still the most important factor in improving Third World health. However, medicines have an important part to play, and it is now generally agreed that for the very poor populations medicines should be restricted to those on an 'essential drugs list' and should be made available as cheaply as possible. A major problem arises,
openaire   +2 more sources